Shoeshine

Latest

Shoeshine

The ‘bemusing’ world of patsy directors

ANALYSIS: Why do shareholders appoint a patsy to their boards just before their companies fail?

Nicholas Pointon Tue, 22 Apr 2025

Last Word

Accounting and independent directors – it’s all about optics

Politics

Health and safety obligations of company directors to be eased

Law

Litigation outlook: Regulators, directors, delays

Law

‘Missed opportunity’ in Companies Act reform

Politics

Warnings that ‘woke’ director duties a waste of time

Shoeshine

SHOESHINE: Investors may be repeating past Ryman mistakes

Are investors about to repeat the mistake they made about Ryman Healthcare during the global financial crisis?

Shoeshine
Fri, 16 Dec 2016

Shoeshine

Shoeshine: Blueberry venture creates an intriguing recipe loaded with risk

Combine seed funding from 40 Maori trusts, taxpayer support from government departments, blueberries and a $30 million capital raise - what do you get?

Shoeshine
Fri, 09 Dec 2016

Shoeshine

Shoeshine: A2’s directors’ fee hike dodges Australia’s two-strike rule

Shoeshine has heard a lot of anecdotes about Australian investors crowding A2 Milk's share register since the company listed on ASX

Shoeshine
Fri, 02 Dec 2016

Shoeshine

Fonterra candidate surprises with no mention of past

When electing new directors most shareholders will read the biographies attached to the voting papers.

Shoeshine
Sat, 26 Nov 2016

Shoeshine

Shoeshine: Will F&P Healthcare hit Trump's wall?

NZ-listed company faces a Tijuana challenge — but one analyst says it's underpriced regardless.

Shoeshine
Sat, 19 Nov 2016

Shoeshine

Shoeshine: Where’s Abano bid money from?

Peter Hutson and associates' partial takeover for Abano Healthcare raises a number of questions, not least where the money is coming from.

Shoeshine
Fri, 11 Nov 2016

Shoeshine

Shoeshine: Sky Vodafone merger still alive

You've probably heard the expression “commentator's curse” before...

Shoeshine
Fri, 04 Nov 2016

Shoeshine

End of the golden weather for infant formula?

When bubbles burst, the fall-out is usually spectacular.

Shoeshine
Fri, 28 Oct 2016

Shoeshine

Shoeshine: Mainfreight’s 100-year view only a small short-term drag

It's unlikely that Mainfreight founder and chairman Bruce Plested loses much sleep when his company's shares periodically underperform the market.

Shoeshine
Sat, 22 Oct 2016

Prev 1 38 39 40 41 42 54 Next

Categories

Analysis

Featured

Shoeshine

The ‘bemusing’ world of patsy directors

Accounting and independent directors – it’s all about optics

Health and safety obligations of company directors to be eased

Litigation outlook: Regulators, directors, delays

‘Missed opportunity’ in Companies Act reform

Warnings that ‘woke’ director duties a waste of time

SHOESHINE: Investors may be repeating past Ryman mistakes

Shoeshine: Blueberry venture creates an intriguing recipe loaded with risk

Shoeshine: A2’s directors’ fee hike dodges Australia’s two-strike rule

Fonterra candidate surprises with no mention of past

Shoeshine: Will F&P Healthcare hit Trump's wall?

Shoeshine: Where’s Abano bid money from?

Shoeshine: Sky Vodafone merger still alive

End of the golden weather for infant formula?

Shoeshine: Mainfreight’s 100-year view only a small short-term drag

Hollywood’s century of cinematic catastrophes

Weekly Wrap: Patsy directors, rare earths, unlawful suspension

Winston Peters’ war against woke and RNZ, the PM, and new roads

Airlines, manufacturers grapple with tariff turmoil

Lodestone ‘on a path’ to $1.5b to $2b of solar investment

The ‘bemusing’ world of patsy directors

An embarrassment of riches

1543 Capital still active despite ‘problematic’ Greg Olliver loan

Winston Peters’ war against woke and RNZ, the PM, and new roads

Aussie rare earths industry a winner from US-China standoff